sodium pantoprazole sesquihydrate

Poland

Drugs containing this active substance

  • CONTIX ZRD

    The medicinal product is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 22.6 mg

    ATC: A02BC02

    Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

  • The medicinal product is used in adults for the treatment of reflux esophagitis, gastric and duodenal ulcer disease, and in conditions related to excessive hydrochloric acid secretion, such as Zollinger-Ellison syndrome.

    Form: powder for preparation of injection solution

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.1 mg

    ATC: A02BC02

    Manufacturer: Takeda GmbH

  • The medicine is used in adults and adolescents over 12 years of age to treat symptoms of gastroesophageal reflux disease (e.g., heartburn, pain when swallowing) and to prevent recurrences of its inflammation. In adults, it also helps to prevent gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs).

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 22.57 mg

    ATC: A02BC02

    Manufacturer: Nycomed GmbH

  • The medicine is used in adults for the treatment of stomach and intestinal diseases related to excessive hydrochloric acid secretion, such as gastroesophageal reflux disease (with esophagitis), gastric and duodenal ulcer disease, and Zollinger-Ellison syndrome.

    Form: powder for preparation of injection solution

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.1 mg

    ATC: A02BC02

    Manufacturer: Krka, d.d., Novo mesto Laboratorios Alcala Farma, S.L. Laboratorios Alcala Farma, S.L. SOFARIMEX Chemical and Pharmaceutical Industry, S.A.

  • The medicine reduces the amount of acid in the stomach. It is used in adults and adolescents from 12 years of age to treat symptoms of gastroesophageal reflux disease (e.g., heartburn, pain when swallowing) and to prevent the recurrence of esophagitis. In adults, it also helps to prevent gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs).

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 22.55 mg

    ATC: A02BC02

    Manufacturer: Logiters, Logistica, Portugal, S.A. McDermott Laboratories Ltd. T/A Gerard Laboratories Mylan Germany GmbH Mylan Hungary Kft.

  • It is used in the treatment of stomach and intestinal diseases related to excess acid, such as reflux esophagitis, gastric and duodenal ulcers, Helicobacter pylori infection (in combination with antibiotics), and Zollinger-Ellison syndrome.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.1 mg

    ATC: A02BC02

    Manufacturer: Logiters, Logistica, Portugal, S.A. McDermott Laboratories Ltd. T/A Gerard Laboratories Mylan Germany GmbH Mylan Hungary Kft.

  • The medicine is used in adults for the treatment of reflux esophagitis, gastric and duodenal ulcer disease, Zollinger-Ellison syndrome, and other conditions related to excessive gastric acid secretion.

    Form: powder for preparation of injection solution

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.11 mg

    ATC: A02BC02

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicine is used in adults for the treatment of, among others, reflux esophagitis, gastric and duodenal ulcer disease, Zollinger-Ellison syndrome, and other conditions related to excessive hydrochloric acid secretion in the stomach.

    Form: powder for preparation of injection solution

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.12 mg

    ATC: A02BC02

    Manufacturer: APL Swift Services (Malta) Ltd.

  • The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 22.55 mg

    ATC: A02BC02

    Manufacturer: Teva Pharma, S.L.U.

  • The medicine is used to treat reflux esophagitis, gastric and duodenal ulcer disease, and Helicobacter pylori infection (in combination with antibiotics). It is also used for Zollinger-Ellison syndrome and other conditions related to excessive gastric acid secretion.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.112 mg

    ATC: A02BC02

    Manufacturer: APL Swift Services (Malta) Ltd.

  • This medicine is used in adults and adolescents over 12 years of age to treat symptoms of gastroesophageal reflux disease (such as heartburn, pain upon swallowing, or acid regurgitation) and to prevent their recurrence. In adults, it also helps to prevent gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs).

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 22.55 mg

    ATC: A02BC02

    Manufacturer: Bluefish Pharmaceuticals AB, Teva Pharma, S.L.U.

  • The medicine is used to treat stomach and intestinal diseases related to excessive acid secretion. It helps in the treatment of reflux esophagitis, gastric and duodenal ulcer disease, and Helicobacter pylori infection (in combination with antibiotics). It is also used in Zollinger-Ellison syndrome.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.1 mg

    ATC: A02BC02

    Manufacturer: Bluefish Pharmaceuticals AB, Teva Pharma, S.L.U.

  • The medicine is used in adults for the treatment of reflux esophagitis, gastric and duodenal ulcer disease, Zollinger-Ellison syndrome, and other conditions associated with excessive gastric acid secretion.

    Form: powder for preparation of injection solution

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.12 mg

    ATC: A02BC02

    Manufacturer: APL Swift Services (Malta) Ltd.

  • The medicine is used in adults and adolescents over 12 years of age for the treatment of symptoms of gastroesophageal reflux disease (such as heartburn, pain upon swallowing, or acid regurgitation) and for the long-term treatment and prevention of recurrence of esophagitis. In adults, the medicine also helps to prevent gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs) if they must take them continuously.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate No input provided

    ATC: A02BC02

    Manufacturer: Idifarma Desarrollo Farmaceutico, S.L. Netpharmalab Consulting Services STM Group S.R.L. Synoptis Industrial Sp. z o.o.

  • The medicine is used in adults for the treatment of reflux esophagitis, gastric and duodenal ulcer disease, Zollinger-Ellison syndrome, and other conditions related to excessive gastric acid secretion.

    Form: powder for preparation of injection solution

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.1 mg

    ATC: A02BC02

    Manufacturer: AS Kalceks

  • The medicine is used to treat symptoms of stomach and intestinal diseases, such as heartburn, acid regurgitation, or pain when swallowing (related to reflux). It also helps in the treatment and prevention of recurrence of esophagitis and protects against gastric and duodenal ulcers in individuals who must take anti-inflammatory drugs (NSAIDs) continuously.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 22.55 mg

    ATC: A02BC02

    Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

  • The medicine is used to treat diseases of the stomach and intestines, such as reflux esophagitis, gastric and duodenal ulcer disease, Helicobacter pylori infection (in combination with antibiotics), and Zollinger-Ellison syndrome.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.1 mg

    ATC: A02BC02

    Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

  • The medicine is used to reduce the secretion of stomach acid. It helps in treating the symptoms of gastroesophageal reflux disease (such as heartburn, pain when swallowing, or acid regurgitation), in the long-term treatment and prevention of recurrence of esophagitis, and in the prevention of gastric and duodenal ulcers in individuals who must take continuous anti-inflammatory drugs (NSAIDs).

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 22.55 mg

    ATC: A02BC02

    Manufacturer: TOWA Pharmaceuticals Europe, S.L.

  • The medicine reduces the secretion of acid in the stomach. It is used in the treatment of reflux esophagitis, gastric and duodenal ulcer diseases, Helicobacter pylori infection (in combination with antibiotics), as well as in Zollinger-Ellison syndrome and other conditions related to excessive acid secretion.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.1 mg

    ATC: A02BC02

    Manufacturer: TOWA Pharmaceuticals Europe, S.L.

  • The medicine is used to treat stomach and intestinal diseases related to excessive hydrochloric acid secretion, such as reflux esophagitis, gastric and duodenal ulcer disease, and Zollinger-Ellison syndrome.

    Form: powder for preparation of injection solution

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.23 mg

    ATC: A02BC02

    Manufacturer: Laboratorio Reig Jofre, S.A.

  • The medicine is used in the treatment of stomach and intestinal diseases related to excessive hydrochloric acid secretion, such as reflux esophagitis, gastric and duodenal ulcers, and Zollinger-Ellison syndrome.

    Form: powder for preparation of injection solution

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.12 mg

    ATC: A02BC02

    Manufacturer: S.C. Terapia S.A.

  • The medicine is used in adults for the treatment of, among others, reflux esophagitis, gastric and duodenal ulcer disease, Zollinger-Ellison syndrome, and other conditions related to excessive gastric acid secretion.

    Form: powder for preparation of injection solution

    Active substance Dosage
    sodium pantoprazole sesquihydrate 44.94 mg

    ATC: A02BC02

    Manufacturer: Laboratorios Normon, S.A.

  • The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 22.575 mg

    ATC: A02BC02

    Manufacturer: Advance Pharma GmbH Sofarimex Industria Quimica e Farmaceutica S.A.

  • The medicine is used in adults for the treatment of, among others, reflux esophagitis, gastric and duodenal ulcer disease, Zollinger-Ellison syndrome, and other conditions related to excessive hydrochloric acid secretion in the stomach.

    Form: powder for preparation of injection solution

    Active substance Dosage
    sodium pantoprazole sesquihydrate 44.94 mg

    ATC: A02BC02

    Manufacturer: Laboratorios Normon, S.A.

  • The medicine is used in adults and adolescents over 12 years of age to treat symptoms of gastroesophageal reflux disease (such as heartburn, pain on swallowing, or acid regurgitation) and for the long-term treatment and prevention of recurrence of esophagitis. In adults, it is also used to prevent gastric and duodenal ulcers in individuals who must take continuous anti-inflammatory drugs (NSAIDs).

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 22.557 mg

    ATC: A02BC02

    Manufacturer: Cemelog BRF Kft. Imed Poland Sp. z o.o. Sun Pharmaceutical Industries Europe B.V. Terapia SA, a company of Ranbaxy

  • The medicine is used in adults and adolescents over 12 years of age for the treatment of reflux esophagitis. In adults, it is also used for the treatment of gastric and duodenal ulcer disease, Helicobacter pylori infection (in combination with antibiotics), and Zollinger-Ellison syndrome and other conditions related to excessive gastric acid secretion.

    Form: tablets, enteric-coated

    Active substance Dosage
    sodium pantoprazole sesquihydrate 45.113 mg

    ATC: A02BC02

    Manufacturer: Terapia SA, a Ranbaxy company